Pre-operative evaluation includes MRI elbow imaging, NPO (nothing by mouth) for 8 hours, blood work (CBC, Coagulation profile), informed consent, and prophylactic antibiotic administration one hour prior to incision.
Post-operative care involves limb elevation, ice therapy, and pain management. The elbow is immobilized in a splint for 1 week, followed by a hinged brace with gradual range-of-motion exercises. Physical therapy begins post-suture removal. Discharge criteria include stable vital signs, effective pain management on oral analgesics, and proper wound care education.
Arthroscopic Osteochondral Lesion Repair (Elbow): A Comprehensive Clinical Guide
1. Introduction and Overview
Arthroscopic osteochondral lesion (OCL) repair of the elbow is a minimally invasive surgical intervention designed to restore the integrity of the articular cartilage and subchondral bone within the humeroulnar or humeroradial joints. These lesions, often manifesting as osteochondritis dissecans (OCD) or post-traumatic chondral defects, represent a significant challenge for the orthopedic surgeon due to the elbow’s unique biomechanical constraints and susceptibility to stiffness.
The primary objective of this procedure is to stabilize unstable osteochondral fragments, debride necrotic tissue, and stimulate biological healing through marrow stimulation techniques or osteochondral autograft/allograft transplantation. By utilizing an arthroscopic approach, surgeons minimize soft tissue trauma, reduce the risk of arthrofibrosis, and expedite the patient’s return to functional activities.
2. Technical Specifications and Mechanisms
The elbow joint is a complex hinge joint that relies on precise articular congruity for stability and range of motion. Osteochondral lesions most frequently involve the capitellum, often secondary to repetitive valgus stress (common in overhead athletes) or repetitive microtrauma.
Biomechanical Considerations
- Capitellar Morphology: The convex surface of the capitellum is highly susceptible to shear forces.
- Vascularity: The subchondral bone of the capitellum has precarious blood supply, making it prone to avascular necrosis (AVN) once a lesion is established.
- Joint Space Constraints: The elbow has limited internal volume, requiring precise instrument triangulation to avoid injury to the radial nerve or the medial collateral ligament (MCL).
Surgical Modalities
| Technique | Mechanism of Action | Clinical Application |
|---|---|---|
| Debridement & Lavage | Removal of loose bodies/instability | Mild, low-grade lesions |
| Marrow Stimulation (Microfracture) | Formation of fibrocartilage clot | Small, contained defects |
| Internal Fixation | Mechanical stabilization of fragments | Large, salvageable fragments |
| Osteochondral Autograft (OATS) | Transfer of hyaline cartilage | Large, cystic, or non-salvageable defects |
3. Clinical Indications and Patient Selection
Proper patient selection is paramount. Clinical assessment must integrate patient age, activity level, symptom duration, and radiographic findings.
Indications
- Symptomatic OCD: Persistent pain, locking, catching, or limited range of motion (ROM) unresponsive to 3–6 months of conservative management.
- Unstable Fragments: Radiographic evidence of fragmentation or "loose bodies" within the joint space.
- Mechanical Blockage: Physical interference with joint extension or flexion.
- Failure of Conservative Therapy: Including physical therapy, activity modification, and NSAID administration.
Clinical Evaluation Pathway
- Physical Examination: Assessment of the "Moving Valgus Stress Test," palpation of the radiocapitellar joint, and formal ROM goniometry.
- Imaging:
- X-ray: AP/Lateral and oblique views to identify lucency or loose bodies.
- MRI (Gold Standard): Evaluation of cartilage integrity, edema in the subchondral bone, and fragment stability.
- CT Scan: Essential for assessing the size of the lesion and the degree of bone cyst formation.
4. Pre-Operative Preparation
Pre-operative planning focuses on optimizing the surgical environment and patient expectations.
- Imaging Review: Surgeons must map the lesion location relative to the radial head and the lateral collateral ligament (LCL) complex.
- Anesthesia: General anesthesia or a regional brachial plexus block is typically employed.
- Patient Positioning: The procedure is commonly performed in the lateral decubitus position or supine with the arm supported on a padded post. A proximal arm tourniquet is standard to ensure a bloodless field for arthroscopic visualization.
- Equipment: 2.7mm or 3.0mm 30-degree arthroscope, motorized shavers, radiofrequency ablation probes, and specialized osteochondral fixation sets (e.g., bioabsorbable headless screws).
5. The Procedure: Step-by-Step
The arthroscopic intervention follows a structured approach to ensure safety and efficacy.
Step 1: Portal Placement
Standard portals include the anterolateral, anteromedial, and proximal lateral portals. Careful dissection is required to avoid the radial nerve (especially with lateral portals).
Step 2: Diagnostic Arthroscopy
Complete visualization of the joint is performed. The surgeon assesses the synovial lining, the status of the coronoid process, and the extent of the OCD lesion.
Step 3: Lesion Preparation
- Debridement: The lesion is cleared of fibrous tissue. The edges are debrided back to stable, bleeding hyaline cartilage.
- Microfracture: If marrow stimulation is chosen, a microfracture pick is used to create holes in the subchondral bone at 3–4mm intervals to stimulate mesenchymal stem cell migration.
Step 4: Fixation or Grafting
- If Fixation: The fragment is reduced and secured using headless compression screws. The screw heads must be buried beneath the cartilage surface to prevent secondary chondral injury.
- If Grafting: A donor plug is harvested from a non-weight-bearing area (e.g., the lateral femoral condyle of the knee) and press-fitted into the prepared recipient site.
Step 5: Closure
The joint is copiously irrigated, portals are closed with non-absorbable monofilament sutures, and a sterile compression dressing is applied.
6. Post-Operative Recovery Protocol
Recovery is staged to protect the biological repair while preventing the catastrophic complication of joint stiffness.
| Phase | Timeline | Focus |
|---|---|---|
| Phase I | 0–2 weeks | Protection, edema control, gentle ROM (passive) |
| Phase II | 2–6 weeks | Gradual increase in active ROM, isometric strengthening |
| Phase III | 6–12 weeks | Progressive resistance training, normalization of ADLs |
| Phase IV | 3–6 months | Sport-specific rehabilitation and return to play |
- Rehabilitation Note: The elbow is notoriously sensitive to immobilization. Early, controlled ROM is critical to preventing contractures.
7. Risks and Complications
While arthroscopy is minimally invasive, the elbow’s proximity to critical neurovascular structures necessitates extreme caution.
- Neurological Injury: The most common risk is neuropraxia of the posterior interosseous nerve (PIN) or the ulnar nerve.
- Arthrofibrosis: Excessive inflammation or prolonged immobilization leading to permanent loss of extension.
- Infection: Rare (<1%), but requires immediate surgical debridement if present.
- Fixation Failure: Migration or loosening of hardware, necessitating revision surgery.
- Persistent Pain: Often linked to underlying chondromalacia or secondary osteoarthritis.
8. Alternative Treatments
- Conservative Management: Physical therapy focusing on dynamic stabilization, activity cessation for 6 months, and orthobiologics (e.g., PRP injections).
- Open Surgery: Indicated for massive lesions where arthroscopic access is insufficient or the bone quality is too poor for arthroscopic fixation.
- Total Elbow Arthroplasty (TEA): Reserved for end-stage post-traumatic arthritis in older, lower-demand patients.
9. Frequently Asked Questions (FAQ)
1. How long does the surgery take?
Typically, the procedure lasts between 60 to 120 minutes, depending on the complexity of the lesion and whether a bone graft is required.
2. Will I have permanent nerve damage?
Neurological complications are uncommon. Most nerve-related issues are temporary "stunning" of the nerve that resolves within a few weeks post-op.
3. When can I return to sports?
For overhead athletes, return to play usually occurs between 6 to 9 months, provided there is radiographic healing and full pain-free ROM.
4. Is the hardware permanent?
Yes, typically bioabsorbable screws are used, which integrate into the bone over time. Metallic screws are rarely used but may need removal if they cause irritation.
5. How successful is the procedure?
Success rates are generally high (80-90%) for appropriately selected patients, particularly those treated before the fragment becomes completely detached.
6. Will I get arthritis in my elbow later?
The surgery aims to prevent post-traumatic arthritis. However, significant initial damage may still lead to future degenerative changes regardless of the success of the repair.
7. Can I drive after surgery?
Driving is restricted until the patient is off opioid pain medication and has regained sufficient control of the arm, usually 2–4 weeks post-op.
8. What if the microfracture doesn't work?
If microfracture fails to produce adequate fibrocartilage, revision options include autologous chondrocyte implantation (ACI) or osteochondral allograft transplantation.
9. Do I need a brace?
Yes, a hinged elbow brace is often prescribed for the first 4–6 weeks to protect the joint while allowing controlled motion.
10. How do I know if the surgery was successful?
Success is measured by the resolution of mechanical symptoms (locking/catching) and the ability to return to pre-injury activity levels without pain.
10. Conclusion
Arthroscopic management of osteochondral lesions of the elbow represents a sophisticated marriage of biomechanical engineering and biological restoration. By prioritizing early diagnosis and precise surgical technique, orthopedic surgeons can significantly alter the natural history of these debilitating lesions. The key to long-term success lies not only in the surgical execution but in a disciplined, patient-specific rehabilitation program that balances the need for tissue healing with the absolute requirement for maintaining functional joint mobility. As technology advances, we anticipate further improvements in scaffold materials and biological augmentation, which will likely continue to improve outcomes for athletes and active individuals alike.